Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia

CEO of Yong Tai Berhad: Introduction of technology is expected to fill the local gap SHENZHEN, China, June 22, 2021 /PRNewswire/ -- On June 21, local time, phase III clinical fieldwork of the In...

Full "IntellAsia: Resources" article